Quantum Biopharma (QNTM) Payables (2018 - 2026)
Quantum Biopharma recorded quarterly Payables of $300549.0 in Q1 2026, down 90.84% quarter-over-quarter from $3.3 million in Q4 2025, and down 72.37% year-over-year from $1.1 million in Q1 2025.
Quantum Biopharma's Payables history runs 9 years deep, the most recent figure standing at $300549.0 for Q1 2026.
- In Q1 2026, Payables fell 72.37% year-over-year to $300549.0; the TTM figure through Mar 2026 stood at $300549.0 (down 72.37% YoY), while the FY2025 annual figure was $3.3 million, down 15.27% from the prior year.
- Payables came in at $300549.0 for Q1 2026 at Quantum Biopharma, down from $3.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $7.4 million in Q4 2022 to a low of $300549.0 in Q1 2022.
- A 5-year average of $1.7 million and a median of $458055.5 in 2022 frame the typical range for Payables.
- Across the five-year window, Payables surged 557.23% in 2025 and plunged 72.37% in 2026, its largest moves.
- Quantum Biopharma's Payables stood at $7.4 million in 2022, then tumbled by 43.38% to $4.2 million in 2023, then retreated by 7.66% to $3.9 million in 2024, then declined by 15.27% to $3.3 million in 2025, then slumped by 90.84% to $300549.0 in 2026.
- According to Business Quant data, Payables over the past three periods registered $300549.0, $3.3 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 80.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,549.00 |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Sep 30, 2024 | 300,549.00 |
| Jun 30, 2024 | 615,562.00 |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 300,549.00 |
| Jun 30, 2023 | 300,549.00 |
| Mar 31, 2023 | 300,549.00 |
| Dec 31, 2022 | 7.41 Mn |
| Sep 30, 2022 | 300,549.00 |
| Jun 30, 2022 | 300,549.00 |
| Mar 31, 2022 | 300,549.00 |
| Dec 31, 2021 | 7.81 Mn |
| Sep 30, 2021 | 300,549.00 |
| Jun 30, 2021 | 300,549.00 |
| Mar 31, 2021 | 358,549.00 |
| Dec 31, 2020 | 4.08 Mn |
| Sep 30, 2020 | 902,088.05 |
| Jun 30, 2020 | 1.32 Mn |
| Mar 31, 2020 | 1.55 Mn |
| Dec 31, 2019 | 4.83 Mn |
| Dec 31, 2018 | 1.32 Mn |